Prosecution Insights
Prosecution Insights
10 pending office actions • 6 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (30%) |
| §102 only | 1 (10%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 5 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGA, KYLE THOMAS | 1 | 61.8% | +40.7% |
| ZAHORIK, AMANDA MARY | 1 | 57.5% | +48.2% |
| SMALL, KATHERINE R | 1 | 67.9% | +30.5% |
| KIM, TAEYOON | 1 | 51.6% | +51.8% |
| ZHU, JIANJIAN | 1 | 61.0% | +83.7% |
| HOLLAND, PAUL J | 1 | 57.3% | +64.7% |
| NGUYEN, QUANG | 1 | 38.1% | +53.0% |
| ARIETI, RUTH SOPHIA | 1 | 45.3% | +72.1% |
| HASAN, KHALEDA B | 1 | 58.5% | +50.1% |
| BURKHART, MICHAEL D | 1 | 62.2% | +11.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | NGUYEN, QUANG | 238d overdue |
| 17836265 | Modified Guide RNAs for Gene Editing | ARIETI, RUTH SOPHIA | 30d overdue |
| 18050333 | Methods of in Vitro Cell Delivery | ZHU, JIANJIAN | 6d |
| 18572155 | METHODS FOR IN VIVO EDITING OF A LIVER GENE | ZAHORIK, AMANDA MARY | — |
| 16651911 | FORMULATIONS | BURKHART, MICHAEL D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | NGUYEN, QUANG | 238d overdue |
| 18415032 | Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four | REGA, KYLE THOMAS | 50d overdue |
| 17836265 | Modified Guide RNAs for Gene Editing | ARIETI, RUTH SOPHIA | 30d overdue |
| 18050333 | Methods of in Vitro Cell Delivery | ZHU, JIANJIAN | 6d |
| 18572155 | METHODS FOR IN VIVO EDITING OF A LIVER GENE | ZAHORIK, AMANDA MARY | — |
| 18339930 | Compositions and Methods for Genetically Modifying CIITA in a Cell | SMALL, KATHERINE R | — |
| 18332390 | Compositions and Methods for Reducing MHC Class II in a Cell | KIM, TAEYOON | — |
| 17965366 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | HOLLAND, PAUL J | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1636 | 2 |
| 1633 | 1 |
| 1656 | 1 |
| 1635 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18415032 | Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | 50d overdue | Pending | Jan 17, 2024 |
| 18572155 | METHODS FOR IN VIVO EDITING OF A LIVER GENE | ZAHORIK, AMANDA MARY | — | §102§103§112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18339930 | Compositions and Methods for Genetically Modifying CIITA in a Cell | SMALL, KATHERINE R | 1633 | §102 | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18332390 | Compositions and Methods for Reducing MHC Class II in a Cell | KIM, TAEYOON | 1631 | §103 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18050333 | Methods of in Vitro Cell Delivery | ZHU, JIANJIAN | 1631 | §102§103§112Other | Non-Final OA | 6d | Pending | Oct 27, 2022 |
| 17965366 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | HOLLAND, PAUL J | 1656 | §103 | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17897878 | LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS | NGUYEN, QUANG | 1631 | §103§112Other | Final Rejection | 238d overdue | Pending | Aug 29, 2022 |
| 17836265 | Modified Guide RNAs for Gene Editing | ARIETI, RUTH SOPHIA | 1635 | §102§103§112Other | Final Rejection | 30d overdue | Pending | Jun 09, 2022 |
| 17735929 | Methods and Compositions for Directed Genome Editing | HASAN, KHALEDA B | 1636 | §103§112DP | Non-Final OA | — | Pending | May 03, 2022 |
| 16651911 | FORMULATIONS | BURKHART, MICHAEL D | 1638 | §102§103 | Final Rejection | — | Pending | Mar 27, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial